Tag: Illumina-Grail Deal
EU Blocks Illumina’s Deal To Buy Grail On Antitrust Grounds
The European Union has blocked Illumina's $7.1 billion acquisition of cancer detection test maker Grail, saying that Illumina failed to address its concerns about the deal...
FTC Appeals Judge’s Decision On Illumina-Grail Deal
The Federal Trade Commission said it would appeal a decision issued on Thursday by the agency's chief administrative judge in favor of Illumina's $7.1...
EU Regulators Soon Block Illumina, Grail Deal: Reports
EU antitrust regulators are expected to veto US life sciences firm Illumina's acquisition of biotechnology company Grail, people familiar with the matter said on Wednesday.
There...
EU Antitrust Regulators Extend Illumina, Grail Deadline To March 4
EU antitrust regulators have extended the deadline for their decision on US life sciences company Illumina’s bid for $8 billion cash-and-stock takeover of Grail...
EU To Conduct A Full-Scale Probe Of Illumina, Grail Deal
US life sciences company Illumina's proposed purchase of cancer test maker Grail Inc faces a lengthy EU antitrust investigation if it does not offer hefty concessions...
EU Watchdog Sets July 27 Deadline For Illumina, Grail Deal
EU antitrust regulators will rule by July 27 whether to clear Illumina’s proposed US$7.1 billion acquisition of cancer test maker Grail Inc, a European...
Illumina, Grail Deal Faces Battles In US & EU
Life-sciences company Illumina is facing a labyrinth of antitrust hurdles on two continents as it seeks to save its planned US$7.1 billion acquisition of...
